Table 4.

Adverse effects

Parameter	Baseline N=241 n (%)	Post-intervention N=480 n (%)	Adjusted effect size (95% CI)*
Dosing errors	75 (31.1)	76 (15.8)	0.41 (0.28, 0.63)
Patients with any complications	15 (6.2)	17 (3.5)	0.59 (0.28, 1.22)
Acute kidney injury	5 (2.1)	1 (0.2)	–
New-onset allergy	3 (1.2)	6 (1.2)	–
Clostridioides difficile infection (hospital-associated)	0 (0.0)	1 (0.2)	–
Neutropenia	1 (0.4)	2 (0.4)	–
Allergy mismatch	1 (0.4)	3 (0.6)	–
Intolerance to medication	4 (1.7)	6 (1.2)	–

*Adjusted for sepsis without shock, Charlson score, MRSA infection risk, febrile neutropenia and palliation status.

MRSA, methicillin-resistant Staphylococcus aureus.